Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings: Week 104 analysis of AIDS clinical trials group (ACTG) A5230

by Kumarasamy N., Aga E., Ribaudo H., Wallis C., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Bartlett J.
Published 2015

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

by Bartlett J., Ribaudo H., Wallis C., Aga E., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Kallungal B., Kumarasamy N.
Published 2017

Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG...

by Celum C., Hong T., Cent A., Donnell D., Morrow R., Baeten J., Firnhaber C., Grinsztejn B., Hosseinipour M., Lalloo U., Nyirenda M., Riviere C., Sanchez J., Santos B., Supparatpinyo K., Hakim J., Kumarasamy N., Campbell T.
Published 2017

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052

by Palumbo P., Wilson E., Piwowar-Manning E., McCauley M., Gamble T., Kumwenda N., Makhema J., Kumarasamy N., Chariyalertsak S., Hakim J., Hosseinipour M., Melo M., Godbole S., Pilotto J., Grinsztejn B., Panchia R., Chen Y., Cohen M., Eshleman S., Fogel J.
Published 2017

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated with Virologic Failure: Results from the Multinational PEARLS (ACTG A5175) Clinical Trial

by Kantor R., Smeaton L., Vardhanabhuti S., Hudelson S., Wallis C., Tripathy S., Morgado M., Saravanan S., Balakrishnan P., Reitsma M., Hart S., Mellors J., Halvas E., Grinsztejn B., Hosseinipour M., Kumwenda J., La Rosa A., Lalloo U., Lama J., Rassool M., Santos B., Supparatpinyo K., Hakim J., Flanigan T., Kumarasamy N., Campbell T., Eshleman S.
Published 2015

Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial

by Eshleman S., Hudelson S., Redd A., Wang L., Debes R., Chen Y., Martens C., Ricklefs S., Selig E., Porcella S., Munshaw S., Ray S., Piwowar-Manning E., McCauley M., Hosseinipour M., Kumwenda J., Hakim J., Chariyalertsak S., De Bruyn G., Grinsztejn B., Kumarasamy N., Makhema J., Mayer K., Pilotto J., Santos B., Quinn T., Cohen M., Hughes J.
Published 2017

Virologic outcomes in early antiretroviral treatment: HPTN 052

by Eshleman S., Wilson E., Zhang X., Ou S., Piwowar-Manning E., Eron J., McCauley M., Gamble T., Gallant J., Hosseinipour M., Kumarasamy N., Hakim J., Kalonga B., Pilotto J., Grinsztejn B., Godbole S., Chotirosniramit N., Santos B., Shava E., Mills L., Panchia R., Mwelase N., Mayer K., Chen Y., Cohen M., Fogel J.
Published 2017

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

by Robertson K., Kumwenda J., Supparatpinyo K., Jiang J., Evans S., Campbell T., Price R., Murphy R., Hall C., Marra C., Marcus C., Berzins B., Masih R., Santos B., Silva M., Kumarasamy N., Walawander A., Nair A., Tripathy S., Kanyama C., Hosseinipour M., Montano S., La Rosa A., Amod F., Sanne I., Firnhaber C., Hakim J., Brouwers P.
Published 2017

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial

by Fogel J., Hudelson S., Ou S., Hart S., Wallis C., Morgado M., Saravanan S., Tripathy S., Hovind L., Piwowar-Manning E., Sabin D., McCauley M., Gamble T., Zhang X., Eron J., Gallant J., Kumwenda J., Makhema J., Kumarasamy N., Chariyalertsak S., Hakim J., Badal-Faesen S., Akelo V., Hosseinipour M., Santos B., Godbole S., Pilotto J., Grinsztejn B., Panchia R., Mayer K., Chen Y., Cohen M., Eshleman S.
Published 2017

Prevention of HIV-1 infection with early antiretroviral therapy

by Cohen M., Chen Y., McCauley M., Gamble T., Hosseinipour M., Kumarasamy N., Hakim J., Kumwenda J., Grinsztejn B., Pilotto J., Godbole S., Mehendale S., Chariyalertsak S., Santos B., Mayer K., Hoffman I., Eshleman S., Piwowar-Manning E., Wang L., Makhema J., Mills L., De Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T., Nielsen-Saines K., Celentano D., Essex M., Fleming T.
Published 2017

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phas...

by Tang M.W., Rhee S.-Y., Bertagnolio S., Ford N., Holmes S., Sigaloff K.C., Hamers R.L., De Wit T.F.R., Fleury H.J., Kanki P.J., Ruxrungtham K., Hawkins C.A., Wallis C.L., Stevens W., Van Zyl G.U., Manosuthi W., Hosseinipour M.C., Ngo-Giang-Huong N., Belec L., Peeters M., Aghokeng A., Bunupuradah T., Burda S., Cane P., Cappelli G., Charpentier C., Dagnra A.Y., Deshpande A.K., El-Katib Z., Eshleman S.H., Fokam J., Gody J.-C., Katzenstein D., Koyalta D.D., Kumwenda J.J., Lallemant M., Lynen L., Marconi V.C., Margot N.A., Moussa S., Ndung'U T., Nyambi P.N., Orrell C., Schapiro J.M., Schuurman R., Sirivichayakul S., Smith D., Zolfo M., Jordan M.R., Shafer R.W.
Published 2014

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

by Campbell T., Smeaton L., Kumarasamy N., Flanigan T., Klingman K., Firnhaber C., Grinsztejn B., Hosseinipour M., Kumwenda J., Lalloo U., Riviere C., Sanchez J., Melo M., Supparatpinyo K., Tripathy S., Martinez A., Nair A., Walawander A., Moran L., Chen Y., Snowden W., Rooney J., Uy J., Schooley R., de Gruttola V., Hakim J., Swann E., Barnett R., Brizz B., Delph Y., Gettinger N., Mitsuyasu R., Eshleman S., Safren S., Fiscus S., Andrade A., Haas D., Amod F., Berthaud V., Bollinger R., Bryson Y., Celentano D., Chilongozi D., Cohen M., Collier A., Currier J., Cu-Uvin S., Eron J., Flexner C., Gallant J., Gulick R., Hammer S., Hoffman I., Kazembe P., Kumwenda N., Lama J., Lawrence J., Maponga C., Martinson F., Mayer K., Nielsen K., Pendame R., Ramratnam B., Sanne I., Severe P., Sirisanthana T., Solomon S., Tabet S., Taha T., van der Horst C., Wanke C., Gormley J., Marcus C., Putnam B., Ntshele S., Loeliger E., Pappa K., Webb N., Shugarts D., Winters M., Descallar R., Steele J., Wulfsohn M., Said F., Chen Y., Martin J., Bischofberger N., Cheng A., Jaffe H., Sharma J., Poongulali S., Cardoso S., Faria D., Berendes S., Burke K., Mngqibisa R., Kanyama C., Kayoyo V., Samaneka W., Chisada A.
Published 2017